Sigal Elliot

Bristol-Myers Squibb Co.

EVP, CSO & President R&D, Director

Avg. Two Year Performance

69% Avg. Purchase Return 30% Compound

(49%) Avg. Sale Return (22%) Compound

Holdings: 195.3K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Major

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions